Screener
Cytokinetics CYTK Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Cytokinetics’s reported figures.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
FAQ
- What is Cytokinetics's enterprise value?
- Cytokinetics (CYTK) reported enterprise value of $11.71B in Q2 2026.
- How has Cytokinetics's enterprise value changed year-over-year?
- Cytokinetics's enterprise value increased by 177.6% year-over-year, from $4.22B to $11.71B.
- What is the long-term trend for Cytokinetics's enterprise value?
- Over 5 years (2020 to 2025), Cytokinetics's enterprise value has grown at a 36.2% compound annual growth rate (CAGR), from $1.72B to $8.06B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Cytokinetics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude